Great Novel Therapeutics Biotech & Medicals
7427.TWO
Taipei Exchange45.60
TWD
+1.05
- -
Total Valuation
Great Novel Therapeutics Biotech & Medicals carries a market capitalization of 1.96B, placing it among publicly traded companies globally.
| Market Cap | 1.96B |
| Enterprise Value | N/A |
Stock Price Statistics
Great Novel Therapeutics Biotech & Medicals's stock has gained approximately 37.97277% over the past 52 weeks. The 50-day moving average sits at 39.28, while the 200-day moving average is 35.34.
| Beta (5Y) | N/A |
| 52-Week Price Change | 37.97277% |
| 50-Day Moving Average | 39.28 |
| 200-Day Moving Average | 35.34 |
| Average Volume (20 Days) | N/A |
Stock Splits
Great Novel Therapeutics Biotech & Medicals's most recent stock split took place on January 31, 2023 with a 10:11 split ratio.
| Last Split Date | 1/31/2023 |
| Split Ratio | 10:11 |